Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Nov 04, 2002
Hemispherx Biopharma RNA Drug Technology Targets New Molecular Defects Uncovered in Prostate Cancer
Oct 21, 2002
HEMISPHERX BIOPHARMA PROFILED ON TOP10MICROCAPSTOCKS.COM
Oct 09, 2002
HEMISPHERX BIOPHARMA RNA DRUG TECHNOLOGY PIPELINE SHOWS THERAPEUTIC PROMISE IN U.S. GOVERNMENT SPONSORED RESEARCH
Sep 03, 2002
Hemispherx Biopharma Will Be Presenting at The Wall Street Analyst Forum in New York on September 9, 2002
Aug 19, 2002
Hemispherx Biopharma Receives Letter of Intent for Potential Multimillion-dollar Investment by Royal Family of United Arab Emirates
Aug 15, 2002
HEMISPHERX ANNOUNCES SECOND QUARTER RESULTS
Jul 30, 2002
HEMISPHERX ANNOUNCES DETAILS ON WALL STREET REPORTER ROUNDTABLE SCHEDULED FOR WEDNESDAY JULY 31ST AT 2 PM EST
Jul 25, 2002
HEMISPHERX ANNOUNCES CONFERENCE CALENDAR
Jul 11, 2002
HEMISPHERX REPORTS NEW AMPLIGEN DATA DEMONSTRATING A MEDIAN 0.5 LOG DROP IN VIRAL LOAD AT INTERNATIONAL AIDS CONFERENCE IN BARCELONA
Jul 11, 2002
HEMISPHERX REPORTS AMPLIGEN DATA DEMONSTRATING A MEDIAN HAART-FREE (STI) INTERVAL OF 25+ WEEKS AT INTERNATIONAL AIDS CONFERENCE IN BARCELONA
74
75
76
77
78
79
80
81
82
<<
<
>
>>
Privacy